LS
Life Sciences at Goldman Sachs Alternatives
Life Sciences at Goldman Sachs Alternatives is a investment firm. It has made 1 investments, with focus areas including Biotech & Life Sciences. 100% of their portfolio is in Biotech & Life Sciences. They made 1 investments in the last 12 months. Their most common stage is series-a (100% of deals).
Portfolio
1
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
 Third Arc Bio Inc. | Series A | $52M | Feb 2026 |
Top Co-Investors
Andreessen Horowitz1 shared
Hillhouse Capital1 shared
Omega Funds1 shared
BVF Partners LP1 shared
funds managed by abrdn Inc.1 shared
Marshall Wace1 shared
Last updated: 4 May 2026